Alex Bataller

57PUBLICATIONS
240CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Aug 13, 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|Apr 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

|Mar 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Alexandre Bazinet, Alex Bataller, Kelly Chien

|Mar 12, 2026
Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

Pageof 10

Frequent Collaborators

29 joint publications

Courtney DiNardo

28 joint publications

Tapan M Kadia

26 joint publications

Hagop M Kantarjian

25 joint publications

Guillermo Garcia-Manero